Nukkleus Inc. Announces Strategic $10.0 Million Private Placement Priced Above-the-Market Under Nasdaq Rules
Nukkleus Inc. Announces Strategic $10.0 Million Private Placement Priced Above-the-Market Under Nasdaq Rules
JERSEY CITY, N.J., Dec. 18, 2024 /PRNewswire/ -- Nukkleus, Inc. (NASDAQ: NUKK), today announced the pricing of a private placement with a single New York-based family office investor. The aggregate gross cash proceeds are expected to be $10.0 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the private placement to finance the proposed acquisition of Star 26 Capital Inc., a defense acquisition company holding 95% ownership in RIMON. RIMON is a leading Israeli supplier of components for the Iron Dome missile defense system, as well as other defense and tactical solutions. for general corporate purposes and working capital.
新泽西州泽西城,2024年12月18日 /PRNewswire/ — Nukkleus, Inc.(纳斯达克股票代码:NUKK)今天宣布了与一家总部位于纽约的家族办公室投资者进行私募的定价。在扣除向配售代理人支付的费用和公司应付的其他发行费用之前,总现金收益预计为1,000万美元。该公司打算使用私募的净收益为收购Star 26 Capital Inc. 的拟议收购提供资金。Star 26 Capital Inc.是一家国防收购公司,持有RIMON95%的所有权。RIMON是以色列领先的Iron Dome导弹防御系统组件以及其他国防和战术解决方案的供应商。用于一般企业用途和营运资金。
In connection with the private placement, the Company is planning to issue an aggregate of 1,666,666 units (the "Offering"). Each unit will be sold at an effective unit price of $6.00 per unit and will consist of one share of restricted common stock (or one pre-prefunded warrant to purchase a share of restricted common stock), and warrants exercisable for one and one-half shares of restricted common stock, exercisable at $6.00 per share. The Offering is priced above-the-market under Nasdaq rules.
在私募方面,公司计划共发行1,666,666个单位(“本次发行”)。每个单位将以每单位6.00美元的有效单位价格出售,将包括一股限制性普通股(或一份用于购买限制性普通股的预先筹资认股权证)和可行使一股半限制性普通股的认股权证,可按每股6.00美元的价格行使。根据纳斯达克的规定,本次发行的价格高于市场。
The closing of the private placement is expected to occur on or about December 19, 2024, subject to the satisfaction of certain customary closing conditions.
私募预计将于2024年12月19日左右完成,但须满足某些惯例成交条件。
Dawson James Securities is acting as the Exclusive Placement Agent for the private placement.
道森詹姆斯证券担任此次私募的独家配售代理。
The securities described above are being sold in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the "Act"), and have not been registered under the Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the Securities and Exchange Commission (the "SEC") covering the resale of the common stock sold in the private placement and the common stock issuable upon exercise of the pre-funded warrants and the warrants sold in the private placement.
上述证券以私募方式出售,不受经修订的1933年《证券法》(“该法”)的注册要求的约束,并且尚未根据该法或适用的州证券法进行注册。因此,除非根据有效的注册声明或该法和相应的州证券法注册要求的适用豁免,否则不得在美国发行或出售这些证券。根据与投资者签订的注册权协议,公司已同意向美国证券交易委员会(“SEC”)提交一份或多份注册声明,涵盖私募中出售的普通股以及行使预先注资认股权证后可发行的普通股和私募中出售的认股权证。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新闻稿不构成出售要约或征求购买本文所述任何证券的要约,在根据任何此类州或司法管辖区的证券法进行注册或获得资格认证之前,在任何州或司法管辖区出售此类证券是非法的,也不应在任何州或司法管辖区出售这些证券。
About Nukkleus, Inc.
关于 Nukkleus, Inc.
Nukkleus, Inc. (NASDAQ: NUKK) is a Nasdaq company, recently announced an acquisition of Star 26 Capital Inc – a defense-focused acquisition company.
Nukkleus, Inc.(纳斯达克股票代码:NUKK)是一家纳斯达克公司,最近宣布收购以国防为重点的收购公司Star 26 Capital Inc.
Forward-Looking Statements
前瞻性陈述
This press release contains forward-looking statements. All statements other than statements of historical facts are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms. Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Risk factors described under "Risk Factors" in Nukkleus' most recently filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law.
本新闻稿包含前瞻性陈述。根据联邦证券法,除历史事实陈述以外的所有陈述均为 “前瞻性陈述”。在某些情况下,您可以使用 “将”、“将”、“期望”、“打算”、“计划”、“目标” 等术语来识别前瞻性陈述,或引用未来事件、条件或情况的类似术语或此类术语的否定词。尽管Nukkleus认为本新闻稿中包含的前瞻性陈述有合理的依据,但这些陈述是基于管理层当前对未来事件和情况的看法和预期,并受到风险和不确定性的影响,所有这些都难以预测,其中许多是公司无法控制的。Nukkleus最近提交的10-k表年度报告中的 “风险因素” 下描述的风险因素可能导致实际业绩、业绩或成就与本新闻稿中前瞻性陈述所表达或暗示的结果存在重大差异,这些风险因素可能导致实际业绩、业绩或成就与本新闻稿中前瞻性陈述所表达或暗示的结果存在重大差异。提醒您不要过分依赖前瞻性陈述,前瞻性陈述仅代表其发表之日。除非法律要求,否则Nukkleus没有义务更新本新闻稿中包含的任何前瞻性陈述以反映本新闻稿发布之日之后发生的事件或存在的情况。
SOURCE Nukkleus, Inc.
来源 Nukkleus, Inc.